Catasys (CATS) Receives Coverage Optimism Score of -0.02

Media headlines about Catasys (NASDAQ:CATS) have been trending somewhat negative recently, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Catasys earned a media sentiment score of -0.02 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 45.0978895062486 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Shares of Catasys (CATS) traded down $0.02 during trading on Thursday, reaching $4.44. The company’s stock had a trading volume of 37,400 shares, compared to its average volume of 71,244. The company has a market capitalization of $70.87, a PE ratio of -2.54 and a beta of 0.13. Catasys has a 52-week low of $3.30 and a 52-week high of $14.00.

Catasys (NASDAQ:CATS) last announced its earnings results on Tuesday, November 14th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.04). analysts predict that Catasys will post -0.89 earnings per share for the current fiscal year.

A number of equities analysts recently commented on CATS shares. Zacks Investment Research downgraded Catasys from a “hold” rating to a “sell” rating in a report on Tuesday, December 19th. ValuEngine downgraded Catasys from a “hold” rating to a “sell” rating in a report on Saturday, October 21st. Taglich Brothers started coverage on Catasys in a report on Wednesday, October 18th. They issued a “speculative buy” rating and a $8.00 price objective on the stock. Finally, Telsey Advisory Group started coverage on Catasys in a report on Wednesday, October 18th. They issued a “buy” rating on the stock.

COPYRIGHT VIOLATION NOTICE: This piece of content was published by Markets Daily and is the property of of Markets Daily. If you are reading this piece of content on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at

About Catasys

Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.

Insider Buying and Selling by Quarter for Catasys (NASDAQ:CATS)

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply